These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20955828)

  • 21. Prevalence of markers of hepatotropic viruses A, B, C and the efficacy of vaccination against hepatitis A and hepatitis B among medical students.
    Jabłkowski M; Kuydowicz J; Strzelczyk J; Białkowska J
    Med Sci Monit; 2002 Nov; 8(11):CR762-6. PubMed ID: 12444381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination of newborns against hepatitis A in the presence of maternally derived antibodies.
    Vidor E
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S42-5. PubMed ID: 17555761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.
    D'Acremont V; Herzog C; Genton B
    J Travel Med; 2006; 13(2):78-83. PubMed ID: 16553593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Seroepidemiology of hepatitis A virus infection in medical and nursing students. The role of vaccination].
    Buti M; Campins M; Jardí R; Navas E; Cotrina M; Llobet E; Vaqué J; Esteban R
    Gastroenterol Hepatol; 1996 Apr; 19(4):199-202. PubMed ID: 8665357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status of liver diseases in Korea: hepatitis A.
    Kwon SY
    Korean J Hepatol; 2009 Dec; 15 Suppl 6():S7-12. PubMed ID: 20037282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization.
    Domínguez A; Bruguera M; Plans P; Costa J; Salleras L
    J Med Virol; 2004 Jun; 73(2):172-6. PubMed ID: 15122789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dynamic model for assessing universal Hepatitis A vaccination in Canada.
    Bauch CT; Rao AS; Pham BZ; Krahn M; Gilca V; Duval B; Chen MH; Tricco AC
    Vaccine; 2007 Feb; 25(10):1719-26. PubMed ID: 17229493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Screening policy for travellers from Rotterdam for hepatitis A antibodies prior to eventual immunization: favourable cost-benefit ratio].
    Reintjes R; Bosman A; de Zwart O
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1777-80. PubMed ID: 10494329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of hepatitis A and hepatitis B by vaccination].
    Buisson Y; Meyran M
    Ann Gastroenterol Hepatol (Paris); 1995 Oct; 31(5):306-8; discussion 308-9. PubMed ID: 8572566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose.
    Fiore AE; Shapiro CN; Sabin K; Labonte K; Darling K; Culver D; Bell BP; Margolis HS
    Pediatr Infect Dis J; 2003 Apr; 22(4):354-9. PubMed ID: 12690277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing travel-related global epidemiology of hepatitis A.
    Steffen R
    Am J Med; 2005 Oct; 118 Suppl 10A():46S-49S. PubMed ID: 16271541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Universal hepatitis A vaccination in the United States: a call for action.
    Lieberman JM; Word BM; Jacobs RJ; Dagan R; Marchant CD
    Pediatr Infect Dis J; 2008 Apr; 27(4):287-91. PubMed ID: 18316993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.
    Valenzuela MT; Jacobs RJ; Arteaga O; Navarrete MS; Meyerhoff AS; Innis BL
    Vaccine; 2005 Jul; 23(32):4110-9. PubMed ID: 15964479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy.
    John A; Chatni S; Narayanan VA; Balakrishnan V; Nair P
    J Indian Med Assoc; 2009 Dec; 107(12):859-61. PubMed ID: 20509469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Advisory Committee Statement (ACS). Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on hepatitis A vaccines for travellers.
    Committee to Advise on Tropical Medicine and Travel
    Can Commun Dis Rep; 2001 Jan; 27():3-12. PubMed ID: 11227824
    [No Abstract]   [Full Text] [Related]  

  • 39. Predictors of travel-related hepatitis A and B among native adult Danes: a nationwide case-control study.
    Nielsen US; Thomsen RW; Cowan S; Larsen CS; Petersen E
    J Infect; 2012 Apr; 64(4):399-408. PubMed ID: 22227464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updated recommendations from the Advisory Committee on Immunization Practices (ACIP) for use of hepatitis A vaccine in close contacts of newly arriving international adoptees.
    ;
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(36):1006-7. PubMed ID: 19763077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.